HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Histone deacetylase 3 (HDAC3) is overexpressed in about half of colon adenocarcinomas.
• HDAC3 plays a role in regulating gene expression and cell growth.
• Understanding HDAC3's function is crucial for developing targeted colon cancer therapies.

Purpose of the Study:

• To investigate the influence of HDAC3 on chromatin modifications and gene expression in colon cancer cells.
• To determine the specific pathways regulated by HDAC3 in colon cancer.
• To explore the potential of targeting HDAC3 for therapeutic interventions.

Main Methods:

• RNA interference (RNAi) approach using short hairpin RNA (shRNA) to knock down HDAC3 expression in colon cancer cell lines (SW480, HT-29, HCT116).
• Analysis of histone modifications, specifically histone H4-K12 acetylation.
• Gene expression profiling using RNA sequencing to assess changes in Wnt and vitamin D signaling pathways.

Main Results:

• HDAC3 knockdown increased histone H4-K12 acetylation in SW480 cells.
• HDAC3 shRNA impacted genes in the Wnt and vitamin D signaling pathways.
• Long-term HDAC3 knockdown suppressed beta-catenin translocation, increased Wnt inhibitors (TLE1, TLE4, SMO), and enhanced vitamin D receptor expression, sensitizing cells to vitamin D.

Conclusions:

• HDAC3 overexpression alters the epigenetic programming of colon cancer cells.
• HDAC3 influences intracellular Wnt signaling and sensitivity to vitamin D-mediated growth regulation.
• Targeting HDAC3 may represent a novel therapeutic strategy for colon cancer by modulating Wnt signaling and vitamin D response.